Is this your firm? Get featured or correct your listing →
Strategy
Recent changes
- Sep 9, 2026Sep 9, 2026Invested in Encoded Therapeutics (Series F, $275M) Encoded Therapeutics (Business Wire via BioSpace)
Portfolio
3 totalRecent Investment Activity
1Track record: led 0 and participated in 1 of 1 tracked venture round · 1 in the last 12 months
| Date | Company | Event | Role | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | Encoded Therapeutics | Series F | Participated | $275M | — | Google Ventures (GV)LeadARCH Venture PartnersIllumina VenturesInvusJanus Henderson InvestorsRTW InvestmentsSoftBank Vision FundVenrockBraidwellFarallon Capital ManagementMatrix Capital ManagementNolan Capital | Encoded Therapeutics (Business Wire via BioSpace) |
Co-Investors
12Similar Firms
overlapping sector, stage or regionLatest Pulse
Illumina Ventures FAQ
What companies has Illumina Ventures invested in?
Illumina Ventures' portfolio includes Encoded Therapeutics, Attovia Therapeutics, Iambic.
Who does Illumina Ventures co-invest with most?
In the rounds Value Add tracks, Illumina Ventures most often invests alongside Abingworth (1 shared deal), ARCH Venture Partners (1 shared deal), ARK Invest (1 shared deal), Ascenta Capital (1 shared deal), Catalio Capital Management (1 shared deal).
Sources & methodologyshow
- Encoded Therapeutics (Business Wire via BioSpace)research database1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.